Cargando…

New developments in immunotherapy for lymphoma

The development of immunotherapies for lymphoma has undergone a revolutionary evolution over the past decades. Since the advent of rituximab as the first successful immunotherapy for B-cell non-Hodgkin lymphoma over two decades ago, a plethora of new immunotherapeutic approaches to treat lymphoma ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyman, Benjamin, Yang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121050/
https://www.ncbi.nlm.nih.gov/pubmed/30197788
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0037